miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer

One of the hallmarks of cancer is sustained angiogenesis. Favorable results have been reported in some breast cancer (BC) patients receiving antiangiogenic therapy with bevacizumab (Bev) in combination with chemotherapy, and further knowledge on how Bev can be optimally combined with conventional tr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Oncol
Päätekijät: Lindholm, Evita Maria, Ragle Aure, Miriam, Haugen, Mads Haugland, Kleivi Sahlberg, Kristine, Kristensen, Vessela N., Nebdal, Daniel, Børresen‐Dale, Anne‐Lise, Lingjærde, Ole Christian, Engebraaten, Olav
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2019
Aiheet:
Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6763780/
https://ncbi.nlm.nih.gov/pubmed/31402562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12561
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia